Plenary Speakers
Prof. Jenny Couper
Australia
View More
Prof. Silva Arslanian
USA
View More
Prof. Vaman Khadilkar
India
View More
Prof. Paul van Trotsenburg
Netherlands

Professor Jenny Couper
Prof Jenny Couper FRACP FAHMS is a practising paediatric endocrinologist. She led the Diabetes and Endocrinology department and clinics at Women’s and Children’s Hospital, South Australia and leads the Discipline of Paediatrics, University of Adelaide.
She leads the Environmental Determinants of Islet Autoimmunity (ENDIA), an internationally unique fully recruited study of 1500 children at-risk of type 1 diabetes who have been followed from pregnancy until they are 10 years or develop insulin-requiring type 1 diabetes.
She has been a co – investigator on all major trials to preserve beta cell function in children with type 1 diabetes in Australia. She has co-authored International Society of Paediatric and Adolescent Diabetes guidelines and JDRFI guidelines for the management of children with pre-symptomatic type 1 diabetes.

Professor Silva Arslanian
Silva Arslanian, M.D., is Professor of Pediatrics, and Professor of Clinical and Translational Science Institute at the University of Pittsburgh, School of Medicine. She holds the Richard L. Day Endowed Chair in Pediatrics at the UPMC Children’s Hospital of Pittsburgh. She is the Director of the Pediatric Clinical and Translational Research Center of the NIH-funded CTSI, and the Director of the Center for Pediatric Research in Obesity & Metabolism at the UPMC Children’s Hospital.
Dr. Arslanian obtained her medical degree from the American University of Beirut and completed her pediatric residency training at the same institution. She completed her fellowship in Pediatric Endocrinology at the UPMC Children’s Hospital of Pittsburgh.
Dr. Arslanian is funded by NIH, Research Foundations and Pharmaceutical Companies. Her research focus is insulin sensitivity and beta cell function during childhood growth and development, in health and disease (prediabetes, Type 2 diabetes, obesity, cardiometabolic syndrome, PCOS), racial disparities in metabolism, and pharmacotherapeutic advances in obesity and type 2 diabetes. Her patient-oriented research provided breakthroughs in discerning the pathophysiology of youth type 2 diabetes, the rapid deterioration in b-cell function and therapeutic options. She was a key player in landmark trials including TODAY (Treatment Options for Type 2 Diabetes in Adolescents and Youth) and RISE (Restoring Insulin SEcretion). She has served the national and international scientific communities in various educational and advisory capacities. Dr. Arslanian has more than 250 publications and is the recipient of several prestigious awards, the latest being the 2023 American Diabetes Association Outstanding Achievement in Clinical Diabetes Research for her seminal contributions in advancing scientific discoveries in youth type 2 diabetes, childhood insulin resistance and beta cell function.

Professor Juliane Léger
Juliane Léger is Professor of Pediatric and Developmental Biology at the University Paris Cité, Assistance Publique-Hôpitaux de Paris, Department of Paediatric Endocrinology and Diabetes of Robert Debré University Hospital, and Head of the French National Reference Centre for Rare Growth and Developmental Endocrine Diseases.
She is an active member of the European society for Paediatric Endocrinology (ESPE) and of the Endocrine Society for many years. She has served as a member of the council and of the Clinical Practice Committee of the ESPE. She is involved with international teaching. She initiated and has been coordinator of the Maghreb School of ESPE. She received the Andrea Prader Price 2022 for her contributions in clinical care, research and teaching in the field of paediatric endocrinology.
She currently serves as Deputy Editor for the European Journal of Endocrinology and is Pediatric chair of MTG Thyroid of Endo-ERN. She had 210 peer-reviewed international publications. Her research interests include various aspects of thyroid, pituitary and pubertal diseases management and epidemiology of rare growth endocrine disorders.

Dr. Vaman Khadilkar
Dr. Vaman Khadilkar, MD, DNB, FIAP, MRCP(UK), is a distinguished Professor of Pediatric Endocrinology at Hirabai Cowasji Jehangir Medical Research Institute (HCJMRI), Jehangir Hospital. He holds an honorary position as a Pediatric Endocrinologist at Bharati Vidyapeeth Medical College, Pune, and is a PhD Guide at Savitribai Phule Pune University.
Dr. Khadilkar’s research interests focus on growth, bone health, obesity, and metabolic syndrome in children. He has received numerous awards and delivered prestigious orations for his contributions to the field.
Dr. Khadilkar’s contributions extend beyond his research and clinical practice. He conceptualized and designed the Indian Academy of Pediatrics growth charts and numerous other Indian anthropometric norms. He has also authored over 300 indexed publications, further solidifying his position as a leading figure in pediatric endocrinology.
His dedication and expertise have been recognized through numerous awards, including over 30 research awards at state, national, and international pediatric endocrine conferences and research meetings, as well as many prestigious orations delivered at state and national pediatric conferences.
Dr. Khadilkar’s passion for research, dedication to clinical care, and commitment to sharing his knowledge have made him a highly respected and influential figure in the field of pediatric endocrinology. His contributions have undoubtedly improved the lives of countless children and continue to shape the future of pediatric care.

